Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126761043 | 12676104 | 3 | F | 20160915 | 20160823 | 20160930 | EXP | NL-APOTEX-2016AP010598 | APOTEX | TROELSTRA NAM, RUTTEN AMF, DUISENBERG-VAN ESSENBERG M.. MIXED DRUG INTOXICATION WITH VALPROIC ACID, QUETIAPINE AND OXAZEPAM COMBINED WITH ALCOHOL. CRITICAL ANALYSIS OF THE TREATMENT RESULTS AFTER RAPID INTERVENTION. [DUTCH].. PHARM-WEEKBL. 2015;150(50):271-274 | 43.00 | YR | M | Y | 0.00000 | 20160930 | OT | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126761043 | 12676104 | 1 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Oral | 45 G, SINGLE | D | 0 | 45 | G | 1X | ||||||
| 126761043 | 12676104 | 2 | PS | QUETIAPINE APOTEX | QUETIAPINE | 1 | Oral | 13 G, SINGLE | D | 90960 | 13 | G | TABLET | 1X | |||||
| 126761043 | 12676104 | 3 | SS | OXAZEPAM APOTEX TABLETTEN | OXAZEPAM | 1 | Oral | 1.1 G, SINGLE | D | 0 | 1.1 | G | TABLET | 1X |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126761043 | 12676104 | 1 | Intentional overdose |
| 126761043 | 12676104 | 2 | Intentional overdose |
| 126761043 | 12676104 | 3 | Intentional overdose |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126761043 | 12676104 | OT |
| 126761043 | 12676104 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126761043 | 12676104 | Blood creatine phosphokinase increased | |
| 126761043 | 12676104 | Coma | |
| 126761043 | 12676104 | Dyspnoea | |
| 126761043 | 12676104 | Electrocardiogram QT prolonged | |
| 126761043 | 12676104 | Haemodynamic instability | |
| 126761043 | 12676104 | Hepatic function abnormal | |
| 126761043 | 12676104 | Hyperammonaemia | |
| 126761043 | 12676104 | Intentional overdose | |
| 126761043 | 12676104 | Metabolic encephalopathy | |
| 126761043 | 12676104 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |